The hardest investment decisions in business are rarely between a good idea and a bad one. More often than not,...
trillions
Unleash Prosperity economist Tomas Philipson argues lengthy FDA approval timelines are delaying lifesaving treatments and calls for a COVID-era "Operation...
Just as the global economy cautiously emerges from one crisis, another is beckoning at the doorstep, one that is completely...
SpaceX is expected to debut on the public markets at a $2 trillion valuation. That number is extraordinary for any...
Millions of Americans check their 401(k) balances each quarter without recognizing the name of the product holding their retirement savings....
Tech companies are scrambling to keep up with skyrocketing AI demand. And many are investing billions in the buildout of...